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Abstract
Objective: Worldwide, diabetes mellitus (DM) is an ever-increasing metabolic dis-
order. A promising approach to the treatment of DM is the implantation of insulin 
producing cells (IPC) that have been derived from various stem cells. Culture condi-
tions play a pivotal role in the quality and quantity of the differentiated cells. In this 
experimental study, we have applied various culture conditions to differentiate human 
umbilical cord matrix-derived mesenchymal cells (hUCMs) into IPCs and measured 
insulin production.
Materials and Methods: In this experimental study, we exposed hUCMs cells to pan-
creatic medium and differentiated them into IPCs in monolayer and suspension cultures. 
Pancreatic medium consisted of serum-free Dulbecco’s modified eagle’s medium Nutri-
ent mixture F12 (DMEM/F12) medium with 17.5 mM glucose supplemented by 10 mM 
nicotinamide, 10 nM exendin-4, 10 nM pentagastrin, 100 pM hepatocyte growth factor, 
and B-27 serum-free supplement. After differentiation, insulin content was analyzed by 
gene expression, immunocytochemistry (IHC) and the chemiluminesence immunoassay 
(CLIA).       
Results: Reverse transcription-polymerase chain reaction (RT-PCR) showed efficient ex-
pressions of NKX2.2, PDX1 and INSULIN genes in both groups. IHC analysis showed 
higher expression of insulin protein in the hanging drop group, and CLIA revealed a 
significant higher insulin production in hanging drops compared with the monolayer group 
following the glucose challenge test.                 
Conclusion: We showed by this novel, simple technique that the suspension culture 
played an important role in differentiation of hUCMs into IPC. This culture was more ef-
ficient than the conventional culture method commonly used in IPC differentiation and 
cultivation.      
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Introduction
Diabetes mellitus (DM) is the most common 
metabolic disorder that affects more than 5% of 
the global population (1). Two types of DM have 
been described, type I (insulin dependent) which 
is caused by the lack of insulin production, and 
type II (non-insulin dependent), which is caused 
by resistance to insulin and the lack of insulin re-
ceptors (2). Insulin dependent diabetes is usually 
caused by autoimmune damage of the pancreatic 
islet (3). Daily injections of insulin is a com-
mon treatment for diabetes type I but continuous 
daily injections reduce quality of life in patients 
and may cause problems such as angiopathy (4). 
Islet transplantation has long been suggested 
for treatment of type I DM which prevents sec-
ondary complications of DM, but inadequacies 
remain such as the limitation of the number of 
donor islets and probable immune system rejec-
tion (5, 6). A promising approach to the treat-
ment of DM is implantation of insulin producing 
cells (IPCs) (7, 8). Current studies have shown 
that different stem cells could successfully dif-
ferentiate into IPCs in vitro to be used as a new 
method for the treatment of DM (9). Human um-
bilical cord matrix-derived mesenchymal cells 
(hUCM), as a valuable source of stem cells, can 
be differentiated into IPCs after induction by 
pancreatic differentiation materials (10). Several 
factors may affect differentiation of the stem 
cells such as extracellular matrix (ECM) pro-
teins, cell-to-cell adhesion, cell-to-cell contact, 
cell shape, surrounding forces and soluble fac-
tors (11). Previous studies have emphasized the 
cell shape as a potent regulator of cell growth 
and function (12) in addition to the ECM as an 
important regulator of cell fate through altera-
tion of the cell shape (13). Although various 
stem cells have successfully been differentiated 
into IPCs (14), insufficient insulin production 
by in vitro generated IPCs is a serious obstacle 
following transplantation of in vitro differenti-
ated cells as treatment of DM in animal models 
and humans (15). Research aims to achieve more 
simple and potent systems for the culture and 
differentiation of stem cells into IPCs. We report 
a novel, efficient and uncomplicated method for 
the differentiation of hUCMs into IPCs that has 
a higher yield of insulin secretion as confirmed 
by the glucose challenge test. 
Materials and Methods
All materials were purchased from Sigma Compa-
ny (USA) unless otherwise stated. The Ethics Com-
mittee at Kerman University of Medical Sciences, 
Kerman, Iran approved this experimental study. 
Human umbilical cord matrix-derived 
mesenchymal cells harvest and cultivation 
In this experimental study, we used a previously 
described method to harvest and culture hUCM (16). 
Briefly, human umbilical cord samples were col-
lected from full term infants delivered by cesarean 
section following written consent from their mothers. 
The samples were transferred in Hank’s balanced salt 
solution to the laboratory. Under sterile conditions, 
Wharton’s jelly was cut into approximately 1 mm3 
pieces and cultured in Dulbecco’s modified eagle’s 
medium Nutrient mixture F12 (DMEM/F12) me-
dium supplemented with 10% fetal bovine serum 
(FBS), 100 IU/ml penicillin, 100 mg/ml strepto-
mycin and 1 μg/ml amphotericin B in 3 cm culture 
plates. The medium was changed every three days 
and the cells were passaged when they reached 80% 
confluency. The adherent cells were trypsinized and 
used for the experiments or cryopreserved for fur-
ther use as described elsewhere (17).
Osteogenic and adipogenic differentiation 
Osteogenic and adipogenic differentiation were 
carried out according to the method described by Gao 
et al. (18). hUCMs (1×104 cell/cm2) were detached 
from the substratum and cultured on glass slides. For 
osteogenic differentiation, the cells were fed with 
osteogenic medium that consisted of low glucose 
DMEM (L-DMEM) supplemented with 10% FBS, 
10 nM dexamethasone, 50 μmol/L ascorbic acid and 
10 mM L β-glycerol phosphate for 21 days. The in-
duced cells were stained by alizarin red and observed 
under an inverted microscope (Olympus, Japan). For 
adipogenic differentiation, the cells were treated for 
14 days with an adipogenic differentiation kit as rec-
ommended by the manufacturer (Invitrogen, USA, 
A1007001). Differentiated cells were stained by oil 
red O and analyzed by a light microscope. As con-
trols, hUCM cells were maintained in the complete 
medium without inducing agents.
Flow cytometry 
Viable hUCMs (1×105 cells) were fixed with 
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4% paraformaldehyde for 15 minutes, washed by 
washing buffer, incubated with 200 μl of 10% goat 
serum for 15 minutes,  and washed again by wash-
ing buffer, after which mouse anti-human antibod-
ies conjugated with phycoerythrin (PE) against 
CD34, CD45, CD73, and CD90 were added. The 
mixture was incubated for one hour at 4˚C (19). 
The samples were washed by washing buffer and 
assessed by flow cytometry (BD FACS Calibur, 
USA). For each antibody, at least 10000 events 
were recorded per sample and data were analyzed 
by WinMDI software (BD Biosciences, CA).
Culture conditions and induction of human 
umbilical cord matrix-derived mesenchymal 
cells for insulin producing cell differentiation 
In the monolayer group, 4×105 viable hUCM cells 
were cultured in a 25 cm2 culture flask. At 80% con-
fluency the medium was changed to pancreatic me-
dium. The cells were fed for 14 days and the medium 
refreshed every 3 days. In the hanging drop group, 
1×104 hUCM cells were suspended in 50 µL droplets 
of pancreatic medium. The droplets were arranged on 
the lid of culture plates and the lid was carefully put 
on the top of the culture plates. Culture plates were 
filled with 5 ml sterile PBS to maintain sufficient hu-
midity to protect droplets from dryness and osmolar-
ity changes (Fig.1). Pancreatic medium consisted of 
serum-free DMEM/F12 medium with 17.5 mM glu-
cose supplemented by 10 mM nicotinamide, 10 nM 
exendin-4, 10 nM pentagastrin, 100 pM hepatocyte 
growth factor, B-27 serum-free supplement (Gibco, 
Australia), 1% penicillin/streptomycin and 1 μg/ml 
amphotericin B.
Fig.1: The cells were suspended in droplets of pancreatic induc-
tion medium and cultured for 14 days.
RNA extraction and cDNA synthesis
Total RNA was extracted using a total RNA puri-
fication kit (Jena Bioscience, Germany) according 
to the manufacturer’s protocol. RNA samples were 
treated with DNase (Ambion, UK) in order to remove 
possible contaminating genomic DNA. The yield of 
RNA was evaluated by UV spectroscopy (NanoDrop 
Thermo, USA). We used 100 ng of total RNA for 
cDNA synthesis as described by the manufacturer 
(Bioneer AccuPower® Cycle Script RT Premix).
Reverse transcription-polymerase chain reaction  
RT-PCR was performed by using a thermal cy-
cler (Bio-Rad c1000, USA) and the following 
primer sequences: GAPDH (87 bp) F: 5´-TG-
CACCACCAACTGCTTAGCT-3´, R: 5´-GGCATG-
GACTGTGGTCATGAG-3´; NKX2.2 (228 bp) F: 
5´-ATGTAAACGTTCTGACAACT-3´, R: 5´-TTCCAT-
ATTTGAGAAATGTTTGC-3´; INSULIN (192 bp) F: 
5´-TTCTTCTACACACCCAAGAC-3´, R: 5´-CTAGTT-
GCAGTAGTTCTCCA-3´; and PDX1 (163 bp) F: 
5´-CTGTGCTCCAGTTCCACACT-3´, R: 5´-ACA-
GCCTCTACCTCGGAACA-3´.
The PCR reaction was performed on 20 µL of 
the following mixture: 10 µL master mix (Am-
plicon, Denmark), 1 µL sense primer (10 pm/L), 
1 µL antisense primer (10 pm/L), 6 µL H2O, and 
2 µL cDNA. PCR was carried out for 35 cycles: 
primary denaturation for 4 minutes at 94˚C, de-
naturation for 30 seconds at 94˚C, annealing 
for 30 seconds at 58-60˚C, and extension for 
30 seconds at 72˚C, with an additional 5 minute 
incubation at 72˚C at the end of the cycle. The 
PCR products were visualized by running on 2% 
agarose gels.
Immunocytochemistry 
Induced cells were fixed in 4% paraformalde-
hyde for 30 minutes, then washed three times by 
phosphate buffer saline (PBS), incubated with 
0.5% Triton X-100 in PBS, incubated in 10% goat 
serum for 45 minutes at room temperature, fol-
lowed by a final incubation overnight with guinea 
pig anti-insulin antibody (Abcam, USA) at 4˚C. 
The next day, the cells were washed three times 
with PBS and incubated with secondary antibody, 
goat anti-guinea pig fluorescein isothioc (FITC, 
Abcam, USA) for 45 minutes at room temperature. 
The nuclei were visualized by incubation of slides 
in 5 µg/mL Hoechst 33258 for 10 minutes after 
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three PBS washes. The cells were analyzed by a 
fluorescence inverted microscope equipped with a 
digital camera (DP71, Olympus, Japan).
In vitro determination of insulin levels 
The differentiated cells were washed twice with 
PBS and placed in L-DMEM that contained 0.5% 
BSA for 12 hours until all glucose within the cells 
were expended. The cells were then incubated in 
high glucose DMEM (H-DMEM, 25 mM glucose) 
and L-DMEM (3 mM glucose) for 2 hours. The 
supernatants obtained from low and high glucose 
cultures were collected, centrifuged and stored at 
−20˚C. Secreted insulin levels were determined by 
the human ultra-sensitive chemiluminesence im-
munoassay (CLIA) method (Liaison, DiaSorin).
Statistical analysis
The experimental data were analyzed using 
SPSS 21 for Windows (SPSS Inc., USA), employ-
ing basic statistical techniques. Other appropriate 
statistical software such as Microsoft Office Ex-
cel 2010 was also used. The independent samples 
t-test was applied to determine the difference be-
tween the treatment groups. A difference of P<0.05 
was considered statistically significant.
Results
Morphologic characteristics of human umbilical 
cord matrix-derived mesenchymal cells 
At 7-10 days after the start of the explants cul-
ture, hUCM cells propagated from the boundary of 
the Wharton’s jelly fragments (Fig.2A). Propagat-
ed cells differed in size and showed both a spindle 
shape and round appearance with high mitotic ac-
tivity (data not shown). After the first passage the 
fibroblast like cells with numerous cytoplasmic ex-
tensions propagated well in the culture and formed 
colonies (Fig.2B). The morphology of the cells re-
mained rather unchanged within the passages.
Osteogenic and adipogenic differentiation
We cultured hUCM cells in osteogenic medium 
for 21 days. Next, the induced cells were examined 
for the presence of Ca2+ aggregates in the ECM. 
Alizarin red staining showed a positive reaction 
within the induced cells (Fig.2C). hUCM cells were 
also seeded in adipogenic medium for 14 days and 
lipid vacuolization was assessed by oil red O stain-
ing. Lipid droplets were detected in the induced 
cells (Fig.2D). Neither osteogenic nor adipogenic 
properties were observed in the control groups.
Flow cytometry analysis
Flow cytometry analysis showed that hUCM 
cells expressed the mesenchymal stem cell (MSC) 
markers CD90 and CD73, but did not express 
CD34 (hematopoietic cell marker) and CD45 (leu-
kocyte common antigen, Fig.3).
Insulin producing cell differentiation 
In the monolayer group, undifferentiated hUC-
Ms which were typically adherent spindle shape 
became round, aggregated and finally formed cell 
clusters under pancreatic induction conditions 
(Fig.4A, B). The cells in the hanging drops aggre-
gated rapidly and formed cell clusters during the 
initial hours of culturing. Cell aggregates were de-
tectable under an inverted microscope (Fig.4C, D).
Gene expression analysis 
In order to determine whether hUCM cells un-
derwent differentiation into IPCs, we assessed gene 
expression by RT-PCR in both the hanging drop and 
monolayer cultures. NKX2.2, PDX1 and INSULIN 
genes were expressed in both groups when compared 
with GAPDH as an internal control gene (Fig.5A, B).
Immunocytochemistry analysis
Immunocytochemical analysis was performed on 
hUCM cells cultured in pancreatic differentiation 
medium for 14 days. Differentiated cells in hanging 
drops and the monolayer culture expressed the insulin 
protein. The proportion of insulin positive cells in the 
monolayer group was 45 ± 4.16, while in the hanging 
drops group it was 72.75 ± 4.19 (Fig.6).
In vitro determination of insulin levels
The supernatants from the hanging drops and mon-
olayer cultures were collected and the amount of in-
sulin was measured by CLIA. The results indicated 
that insulin secretion during the exposure of IPCs to 
high glucose medium was higher than low glucose 
medium in both systems. Insulin secretion in the L-
DMEM medium was 6.58 ± 0.57 mIU/L in the mon-
olayer culture and 90 ± 7.6 mIU/L in hanging drops. 
In H-DMEM medium, this value increased to 12.86 
± 0.55 (monolayer) and ≥500 (mIU/L) for the hang-
ing drops (Fig.7A). Glucose challenge test revealed 
a 2-fold increase in the monolayer culture and a 5.5-
fold increase in the hanging drops (Fig.7B).
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Fig.2: A. Human umbilical cord matrix-derived mesenchymal cells (hUCM) propagated from the boundary of Wharton’s jelly fragments, B. 
Colony formation in hUCM cells, C. Ca2+ aggregation in the extracellular matrix (ECM) was shown by alizarin red staining and D. Oil red O 
staining showed the presence of lipid droplets in the cytoplasm of the induced cells (magnification A, B: ×100, C and D: ×200).
Fig.3: Flow cytometry analysis of mesenchymal stem cell (MSC) marker expression in human umbilical cord matrix-derived mesenchymal 
cells (hUCM) shows the expression of MSC markers CD90 and CD73, and lack of expression of CD34 and CD45. The respective immuno-
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Fig.4: A. Morphology of passage 3 human umbilical cord matrix-derived mesenchymal cells (hUCM), B. Morphological changes following 
pancreatic differentiation in the monolayer, C. and D. hanging drop culture after 14 days (magnification A, B, D: ×200 and C: ×40)
Fig.5: Gene expressions in the monolayer and hanging drops groups. A. GAPDH (87 bp), NKX2.2 (228 bp) and INSULIN (192 bp) and B. 
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Fig.6: Immunocytochemical analyses were carried out on the hanging drops, monolayer and control groups for insulin protein expression 
after pancreatic differentiation for 14 days. The cell nuclei were counterstained with Hoechst (magnification: ×100).
Fig.7: Insulin secretion was assayed in the monolayer, hanging drops and control groups following exposure to high and low glucose media. 
Insulin secretion following culture in low glucose medium was significantly higher in the hanging drops group compared with the control and 
monolayer groups (#; P<0.000). Insulin secretion in high glucose medium was significantly higher in the monolayer group compared with the 
control group (*; P<0.02), while in the hanging drop group insulin secretion was significantly higher when compared with the control and 
monolayer groups (**; P<0.000); (A. n=3-5). Fold increase of insulin secretion following glucose challenge test was also significantly higher (*; 
P<0.004) in the hanging drop group compared with the monolayer group (B. n=3-5). Data were expressed as mean ± SE.
A B
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Discussion
According to the results, hUCM cells success-
fully differentiated into IPCs in two-dimensional 
(2D) and three-dimensional (3D) environments, 
as confirmed by gene expression and protein 
synthesis. CLIA evaluation of in vitro insulin 
secretion showed that both groups secreted in-
sulin and responded to the glucose challenge 
test, however the rate of insulin secretion in the 
hanging drops group was significantly higher 
(about 40-fold) than the monolayer group. Ex-
posure of induced cells to low and high glucose 
environments resulted in 2-fold insulin secre-
tion in the monolayer group and a 5.5-fold in-
sulin secretion in the hanging drops group. In 
vitro exposure of islets of Langerhans to low 
and high glucose conditions was reported to ac-
celerate insulin secretion at a rate of 3- to 4-fold 
(20, 21), higher than observed in the monolayer 
group but lower than the hanging drop group in 
our experiments. It could be concluded by com-
paring our results with the results reported thus 
far from the in vitro culture of islets of Langer-
hans that the hanging drop system might work 
similar to in vitro islet cells insulin secretion.
Until now, a number of studies used different 
protocols to differentiate stem cells into IPCs. 
Wang et al. (5) reported insulin secretion of 
9.54 ± 4.86 mmol/L in induced Wharton’s jelly 
cells without the glucose challenge test. Kim et 
al. (22) compared the IPC differentiation abil-
ity between four types of MSCs derived from 
bone marrow, adipose tissue, periosteum and 
Wharton’s jelly. Although gene expression and 
protein secretion was observed in all groups of 
cells, only IPCs derived from the periosteum 
efficiently responded to the glucose challenge 
test. In another study, Wu et al. (23) differenti-
ated hUCMs and bone marrow–derived MSCs 
(BM-MSCs) into IPCs. They reported higher 
insulin secretion in hUCMs (35 mIU/L) follow-
ing the glucose challenge test compared to BM-
MSCs (25 mIU/L). The current study used the 
glucose challenge test as a reliable physiologic 
test for the evaluation of insulin secretion. The 
results have shown a large amount of insulin 
secretion in the 3D culture (≥500 mIU/L) com-
pared with 13 mIU/L in the 2D culture. The cell 
environment, including the cell niche and cul-
ture conditions play an essential role in cell fate 
and their behavior (24). Cell migration, prolif-
eration, differentiation and apoptosis is affected 
by the ECM (25). The ECM is composed of 
soluble and insoluble factors that affect stem 
cell differentiation. The soluble factors con-
sist of growth factors and cytokines, whereas 
insoluble factors comprise cell adhesion mol-
ecules, cell shape, mechanical forces from the 
surrounding environment, and substrate rigidity 
(11). A number of related studies have shown 
that the ECM affects cell fate through a change 
in the cell’s shape (13). The cell shape is a po-
tent regulator of cell growth and function (12) 
as well as  embryonic development and stem 
cell differentiation (13). For example, a change 
in the cell shape has been implicated as a po-
tential mechanism that regulates myocardial 
development (26). Maintenance of chondrocyte 
shape in a round configuration has been shown 
to increase synthesis and secretion of sulfate 
matrix such that growth of the chondrocytes in 
a flat (2D) culture caused them to dedifferenti-
ate and shift into a fibroblast phonotype. How-
ever maintenance of chondrocytes in the 3D 
environment preserved their normal phonotype 
(13). A round shape in lipid cells allows them 
to save maximum lipid droplet in adipose tis-
sue, while cell spreading facilitates osteoblast 
matrix formation (27). Changes in morphology 
are created by changes in cadherin, integrin and 
other cytoskeletal protein expressions during 
stem cell commitment (28). McBeath et al. (27) 
have demonstrated that the cell shape regulated 
commitment of human MSCs to an adipocyte 
or osteoblast fate. The round shape of cells in 
hanging drops might have led to a higher degree 
of differentiation into IPCs. This was confirmed 
by IHC results where the number and intensity 
of the IPCs was prominent in the 3D culture and 
allowed the cells to secrete more insulin gran-
ules than the cells in the monolayer culture.
Cell to cell adhesion is another important 
factor in the stem cell fate (13). An essential 
molecule in cell-cell adhesion is cadherin (29). 
Minami et al. (30) have shown that pancreatic 
exocrine acinar cells can change into pancreatic 
endocrine cells in the presence of cadherin mol-
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ecules. Cadherin inhibition blocks trans-dif-
ferentiation into IPCs. The use of an antibody 
against E-cadherin suppresses genes that induce 
pancreatic characteristics. In the hanging drops 
method, all of the cells aggregated in the center 
of the drops due to gravity and made a rather 
homogenous cell cluster. Cell shape, cell aggre-
gation, and cell clustering in IPCs could have 
resulted in the higher insulin production in the 
3D culture condition.
Conclusion
We have shown by a novel and simple method 
that differentiation of human umbilical cord ma-
trix derived mesenchymal cells into insulin secret-
ing cells is more efficient in 3D culture than 2D 
culture in protein continuance, insulin secretion, 
and response to the glucose challenge test.
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